0
     

Report Added
Report already added
Healthcare Providers Market Summary, Competitive Analysis and Forecast, 2016-2025

Healthcare Providers Market Summary, Competitive Analysis and Forecast, 2016-2025

Summary

Global Healthcare Providers industry profile provides top-line qualitative and quantitative summary information including: Sector size (value 2017-21, and forecast to 2026). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the Sector.

Key Highlights

- The healthcare providers sector is valued as total expenditure on healthcare in each country. This includes final consumption spending on healthcare goods and services.
- Goods and services in this sector include inpatient, outpatient, long-term medical care, medical goods including pharmaceuticals and supplies, and collective services and capital formation such as administration requirements and development costs.
- Public spending (e.g., by national and local governments and social security schemes) and private spending (e.g., payments made by private-sector health insurers and individual out-of-pocket expenditures) are both included.
- Note that with regards to distribution data (whereby data is broken down to private or government expenditure), the government expenditure segment also includes healthcare insurance funded by private insurers where such insurance is mandatory, for example in the United States. Any other non-mandatory privately funded insurance comes under the "private" segment.
- All market data and forecasts are represented in nominal terms (i.e., without adjustment for inflation) and all currency conversions used in the creation of this report have been calculated using constant 2021 annual average exchange rates.
- The global healthcare providers sector had total revenues of $9,423.9 billion in 2021, representing a compound annual growth rate (CAGR) of 5.4% between 2017 and 2021.
- The outpatient care segment was the sector's most lucrative in 2021, with total revenues of $3,113.4 billion, equivalent to 33% of the sector's overall value.
- The value of the global healthcare providers sector grew by 5.3% in 2021, a weaker rate compared to 2020, as a result of the health expenditure in response to the COVID-19 pandemic.

Scope

- Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the global healthcare providers Sector
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the global healthcare providers Sector
- Leading company profiles reveal details of key healthcare providers Sector players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the global healthcare providers Sector with five year forecasts

Reasons to Buy

- What was the size of the global healthcare providers Sector by value in 2021?
- What will be the size of the global healthcare providers Sector in 2026?
- What factors are affecting the strength of competition in the global healthcare providers Sector?
- How has the Sector performed over the last five years?
- What are the main segments that make up the global healthcare providers Sector?

Table of Contents

1 EXECUTIVE SUMMARY
1.1. Market value
1.2. Market value forecast
1.3. Category segmentation
1.4. Geography segmentation
1.5. Competitive Landscape
2 Introduction
2.1. What is this report about?
2.2. Who is the target reader?
2.3. How to use this report
2.4. Definitions
3 Global Healthcare Providers
3.1. Market Overview
3.2. Market Data
3.3. Market Segmentation
3.4. Market outlook
3.5. Five forces analysis
4 Macroeconomic Indicators
4.1. Country data
5 Healthcare Providers in Asia-Pacific
5.1. Market Overview
5.2. Market Data
5.3. Market Segmentation
5.4. Market outlook
5.5. Five forces analysis
6 Healthcare Providers in Europe
6.1. Market Overview
6.2. Market Data
6.3. Market Segmentation
6.4. Market outlook
6.5. Five forces analysis
7 Macroeconomic Indicators
7.1. Country data
8 Healthcare Providers in France
8.1. Market Overview
8.2. Market Data
8.3. Market Segmentation
8.4. Market outlook
8.5. Five forces analysis
9 Macroeconomic Indicators
9.1. Country data
10 Healthcare Providers in Germany
10.1. Market Overview
10.2. Market Data
10.3. Market Segmentation
10.4. Market outlook
10.5. Five forces analysis
11 Macroeconomic Indicators
11.1. Country data
12 Healthcare Providers in Italy
12.1. Market Overview
12.2. Market Data
12.3. Market Segmentation
12.4. Market outlook
12.5. Five forces analysis
13 Macroeconomic Indicators
13.1. Country data
14 Healthcare Providers in Japan
14.1. Market Overview
14.2. Market Data
14.3. Market Segmentation
14.4. Market outlook
14.5. Five forces analysis
15 Macroeconomic Indicators
15.1. Country data
16 Healthcare Providers in Australia
16.1. Market Overview
16.2. Market Data
16.3. Market Segmentation
16.4. Market outlook
16.5. Five forces analysis
17 Macroeconomic Indicators
17.1. Country data
18 Healthcare Providers in Canada
18.1. Market Overview
18.2. Market Data
18.3. Market Segmentation
18.4. Market outlook
18.5. Five forces analysis
19 Macroeconomic Indicators
19.1. Country data
20 Healthcare Providers in China
20.1. Market Overview
20.2. Market Data
20.3. Market Segmentation
20.4. Market outlook
20.5. Five forces analysis
21 Macroeconomic Indicators
21.1. Country data
22 Healthcare Providers in The Netherlands
22.1. Market Overview
22.2. Market Data
22.3. Market Segmentation
22.4. Market outlook
22.5. Five forces analysis
23 Macroeconomic Indicators
23.1. Country data
24 Healthcare Providers in Spain
24.1. Market Overview
24.2. Market Data
24.3. Market Segmentation
24.4. Market outlook
24.5. Five forces analysis
25 Macroeconomic Indicators
25.1. Country data
26 Healthcare Providers in The United Kingdom
26.1. Market Overview
26.2. Market Data
26.3. Market Segmentation
26.4. Market outlook
26.5. Five forces analysis
27 Macroeconomic Indicators
27.1. Country data
28 Healthcare Providers in The United States
28.1. Market Overview
28.2. Market Data
28.3. Market Segmentation
28.4. Market outlook
28.5. Five forces analysis
29 Macroeconomic Indicators
29.1. Country data
30 Company Profiles
31 Appendix
31.1. Methodology
31.2. About MarketLine

List of Tables
Table 1: Global healthcare providers sector value: $ billion, 2017-21
Table 2: Global healthcare providers sector category segmentation: $ billion, 2021
Table 3: Global healthcare providers sector geography segmentation: $ billion, 2021
Table 4: Global healthcare providers sector distribution: % share, by value, 2021
Table 5: Global healthcare providers sector value forecast: $ billion, 2021-26
Table 6: Global size of population (million), 2017-21
Table 7: Global gdp (constant 2005 prices, $ billion), 2017-21
Table 8: Global gdp (current prices, $ billion), 2017-21
Table 9: Global inflation, 2017-21
Table 10: Global consumer price index (absolute), 2017-21
Table 11: Global exchange rate, 2017-21
Table 12: Asia-Pacific healthcare providers sector value: $ billion, 2017-21
Table 13: Asia-Pacific healthcare providers sector category segmentation: $ billion, 2021
Table 14: Asia-Pacific healthcare providers sector geography segmentation: $ billion, 2021
Table 15: Asia-Pacific healthcare providers sector distribution: % share, by value, 2021
Table 16: Asia-Pacific healthcare providers sector value forecast: $ billion, 2021-26
Table 17: Europe healthcare providers sector value: $ billion, 2017-21
Table 18: Europe healthcare providers sector category segmentation: $ billion, 2021
Table 19: Europe healthcare providers sector geography segmentation: $ billion, 2021
Table 20: Europe healthcare providers sector distribution: % share, by value, 2021
Table 21: Europe healthcare providers sector value forecast: $ billion, 2021-26
Table 22: Europe size of population (million), 2017-21
Table 23: Europe gdp (constant 2005 prices, $ billion), 2017-21
Table 24: Europe gdp (current prices, $ billion), 2017-21
Table 25: Europe inflation, 2017-21
Table 26: Europe consumer price index (absolute), 2017-21
Table 27: Europe exchange rate, 2017-21
Table 28: France healthcare providers sector value: $ billion, 2017-21
Table 29: France healthcare providers sector category segmentation: $ billion, 2021
Table 30: France healthcare providers sector geography segmentation: $ billion, 2021
Table 31: France healthcare providers sector distribution: % share, by value, 2021
Table 32: France healthcare providers sector value forecast: $ billion, 2021-26
Table 33: France size of population (million), 2017-21
Table 34: France gdp (constant 2005 prices, $ billion), 2017-21
Table 35: France gdp (current prices, $ billion), 2017-21
Table 36: France inflation, 2017-21
Table 37: France consumer price index (absolute), 2017-21
Table 38: France exchange rate, 2017-21
Table 39: Germany healthcare providers sector value: $ billion, 2017-21
Table 40: Germany healthcare providers sector category segmentation: $ billion, 2021
Table 41: Germany healthcare providers sector geography segmentation: $ billion, 2021
Table 42: Germany healthcare providers sector distribution: % share, by value, 2021
Table 43: Germany healthcare providers sector value forecast: $ billion, 2021-26
Table 44: Germany size of population (million), 2017-21
Table 45: Germany gdp (constant 2005 prices, $ billion), 2017-21
Table 46: Germany gdp (current prices, $ billion), 2017-21
Table 47: Germany inflation, 2017-21
Table 48: Germany consumer price index (absolute), 2017-21
Table 49: Germany exchange rate, 2017-21
Table 50: Italy healthcare providers sector value: $ billion, 2017-21
Table 51: Italy healthcare providers sector category segmentation: $ billion, 2021
Table 52: Italy healthcare providers sector geography segmentation: $ billion, 2021
Table 53: Italy healthcare providers sector distribution: % share, by value, 2021
Table 54: Italy healthcare providers sector value forecast: $ billion, 2021-26
Table 55: Italy size of population (million), 2017-21
Table 56: Italy gdp (constant 2005 prices, $ billion), 2017-21
Table 57: Italy gdp (current prices, $ billion), 2017-21
Table 58: Italy inflation, 2017-21
Table 59: Italy consumer price index (absolute), 2017-21
Table 60: Italy exchange rate, 2017-21
Table 61: Japan healthcare providers sector value: $ billion, 2017-21
Table 62: Japan healthcare providers sector category segmentation: $ billion, 2021
Table 63: Japan healthcare providers sector geography segmentation: $ billion, 2021
Table 64: Japan healthcare providers sector distribution: % share, by value, 2021
Table 65: Japan healthcare providers sector value forecast: $ billion, 2021-26
Table 66: Japan size of population (million), 2017-21
Table 67: Japan gdp (constant 2005 prices, $ billion), 2017-21
Table 68: Japan gdp (current prices, $ billion), 2017-21
Table 69: Japan inflation, 2017-21
Table 70: Japan consumer price index (absolute), 2017-21
Table 71: Japan exchange rate, 2017-21
Table 72: Australia healthcare providers sector value: $ billion, 2017-21
Table 73: Australia healthcare providers sector category segmentation: $ billion, 2021
Table 74: Australia healthcare providers sector geography segmentation: $ billion, 2021
Table 75: Australia healthcare providers sector distribution: % share, by value, 2021
Table 76: Australia healthcare providers sector value forecast: $ billion, 2021-26
Table 77: Australia size of population (million), 2017-21
Table 78: Australia gdp (constant 2005 prices, $ billion), 2017-21
Table 79: Australia gdp (current prices, $ billion), 2017-21
Table 80: Australia inflation, 2017-21

List of Figures
Figure 1: Global healthcare providers sector value: $ billion, 2017-21
Figure 2: Global healthcare providers sector category segmentation: % share, by value, 2021
Figure 3: Global healthcare providers sector geography segmentation: % share, by value, 2021
Figure 4: Global healthcare providers sector distribution: % share, by value, 2021
Figure 5: Global healthcare providers sector value forecast: $ billion, 2021-26
Figure 6: Forces driving competition in the global healthcare providers sector, 2021
Figure 7: Drivers of buyer power in the global healthcare providers sector, 2021
Figure 8: Drivers of supplier power in the global healthcare providers sector, 2021
Figure 9: Factors influencing the likelihood of new entrants in the global healthcare providers sector, 2021
Figure 10: Factors influencing the threat of substitutes in the global healthcare providers sector, 2021
Figure 11: Drivers of degree of rivalry in the global healthcare providers sector, 2021
Figure 12: Asia-Pacific healthcare providers sector value: $ billion, 2017-21
Figure 13: Asia-Pacific healthcare providers sector category segmentation: % share, by value, 2021
Figure 14: Asia-Pacific healthcare providers sector geography segmentation: % share, by value, 2021
Figure 15: Asia-Pacific healthcare providers sector distribution: % share, by value, 2021
Figure 16: Asia-Pacific healthcare providers sector value forecast: $ billion, 2021-26
Figure 17: Forces driving competition in the healthcare providers sector in Asia-Pacific, 2021
Figure 18: Drivers of buyer power in the healthcare providers sector in Asia-Pacific, 2021
Figure 19: Drivers of supplier power in the healthcare providers sector in Asia-Pacific, 2021
Figure 20: Factors influencing the likelihood of new entrants in the healthcare providers sector in Asia-Pacific, 2021
Figure 21: Factors influencing the threat of substitutes in the healthcare providers sector in Asia-Pacific, 2021
Figure 22: Drivers of degree of rivalry in the healthcare providers sector in Asia-Pacific, 2021
Figure 23: Europe healthcare providers sector value: $ billion, 2017-21
Figure 24: Europe healthcare providers sector category segmentation: % share, by value, 2021
Figure 25: Europe healthcare providers sector geography segmentation: % share, by value, 2021
Figure 26: Europe healthcare providers sector distribution: % share, by value, 2021
Figure 27: Europe healthcare providers sector value forecast: $ billion, 2021-26
Figure 28: Forces driving competition in the healthcare providers sector in Europe, 2021
Figure 29: Drivers of buyer power in the healthcare providers sector in Europe, 2021
Figure 30: Drivers of supplier power in the healthcare providers sector in Europe, 2021
Figure 31: Factors influencing the likelihood of new entrants in the healthcare providers sector in Europe, 2021
Figure 32: Factors influencing the threat of substitutes in the healthcare providers sector in Europe, 2021
Figure 33: Drivers of degree of rivalry in the healthcare providers sector in Europe, 2021
Figure 34: France healthcare providers sector value: $ billion, 2017-21
Figure 35: France healthcare providers sector category segmentation: % share, by value, 2021
Figure 36: France healthcare providers sector geography segmentation: % share, by value, 2021
Figure 37: France healthcare providers sector distribution: % share, by value, 2021
Figure 38: France healthcare providers sector value forecast: $ billion, 2021-26
Figure 39: Forces driving competition in the healthcare providers sector in France, 2021
Figure 40: Drivers of buyer power in the healthcare providers sector in France, 2021
Figure 41: Drivers of supplier power in the healthcare providers sector in France, 2021
Figure 42: Factors influencing the likelihood of new entrants in the healthcare providers sector in France, 2021
Figure 43: Factors influencing the threat of substitutes in the healthcare providers sector in France, 2021
Figure 44: Drivers of degree of rivalry in the healthcare providers sector in France, 2021
Figure 45: Germany healthcare providers sector value: $ billion, 2017-21
Figure 46: Germany healthcare providers sector category segmentation: % share, by value, 2021
Figure 47: Germany healthcare providers sector geography segmentation: % share, by value, 2021
Figure 48: Germany healthcare providers sector distribution: % share, by value, 2021
Figure 49: Germany healthcare providers sector value forecast: $ billion, 2021-26
Figure 50: Forces driving competition in the healthcare providers sector in Germany, 2021
Figure 51: Drivers of buyer power in the healthcare providers sector in Germany, 2021
Figure 52: Drivers of supplier power in the healthcare providers sector in Germany, 2021
Figure 53: Factors influencing the likelihood of new entrants in the healthcare providers sector in Germany, 2021
Figure 54: Factors influencing the threat of substitutes in the healthcare providers sector in Germany, 2021
Figure 55: Drivers of degree of rivalry in the healthcare providers sector in Germany, 2021
Figure 56: Italy healthcare providers sector value: $ billion, 2017-21
Figure 57: Italy healthcare providers sector category segmentation: % share, by value, 2021
Figure 58: Italy healthcare providers sector geography segmentation: % share, by value, 2021
Figure 59: Italy healthcare providers sector distribution: % share, by value, 2021
Figure 60: Italy healthcare providers sector value forecast: $ billion, 2021-26
Figure 61: Forces driving competition in the healthcare providers sector in Italy, 2021
Figure 62: Drivers of buyer power in the healthcare providers sector in Italy, 2021
Figure 63: Drivers of supplier power in the healthcare providers sector in Italy, 2021
Figure 64: Factors influencing the likelihood of new entrants in the healthcare providers sector in Italy, 2021
Figure 65: Factors influencing the threat of substitutes in the healthcare providers sector in Italy, 2021
Figure 66: Drivers of degree of rivalry in the healthcare providers sector in Italy, 2021
Figure 67: Japan healthcare providers sector value: $ billion, 2017-21
Figure 68: Japan healthcare providers sector category segmentation: % share, by value, 2021
Figure 69: Japan healthcare providers sector geography segmentation: % share, by value, 2021
Figure 70: Japan healthcare providers sector distribution: % share, by value, 2021
Figure 71: Japan healthcare providers sector value forecast: $ billion, 2021-26
Figure 72: Forces driving competition in the healthcare providers sector in Japan, 2021
Figure 73: Drivers of buyer power in the healthcare providers sector in Japan, 2021
Figure 74: Drivers of supplier power in the healthcare providers sector in Japan, 2021
Figure 75: Factors influencing the likelihood of new entrants in the healthcare providers sector in Japan, 2021
Figure 76: Factors influencing the threat of substitutes in the healthcare providers sector in Japan, 2021
Figure 77: Drivers of degree of rivalry in the healthcare providers sector in Japan, 2021
Figure 78: Australia healthcare providers sector value: $ billion, 2017-21
Figure 79: Australia healthcare providers sector category segmentation: % share, by value, 2021
Figure 80: Australia healthcare providers sector geography segmentation: % share, by value, 2021

Report Title: Healthcare Providers Market Summary, Competitive Analysis and Forecast, 2016-2025


Your Details
Valid Invalid number

SELECT A FORMAT

ADD TO CART BUY NOW

Related Report

Telecom operators’ strategies in the health market

Telecom operators’ strategies in the health market

China Bispecific Antibody Market Opportunity & Clinical Trials Insight 2028

China Bispecific Antibody Market Opportunity & Clinical Trials Insight 2028

2022 Vietnam Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests -- High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline

2022 Vietnam Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests -- High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline

2022 Venezuela Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests -- High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline

2022 Venezuela Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests -- High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline

2022 Uruguay Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests -- High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline

2022 Uruguay Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests -- High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline

2022 United Arab Emirates Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests -- High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline

2022 United Arab Emirates Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests -- High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline